These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8761723

  • 1. Resistance to quinolones in mycobacteria.
    Cambau E, Jarlier V.
    Res Microbiol; 1996; 147(1-2):52-9. PubMed ID: 8761723
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.
    Zhou J, Dong Y, Zhao X, Lee S, Amin A, Ramaswamy S, Domagala J, Musser JM, Drlica K.
    J Infect Dis; 2000 Aug; 182(2):517-25. PubMed ID: 10915083
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
    Onodera Y, Tanaka M, Sato K.
    J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418
    [Abstract] [Full Text] [Related]

  • 6. Activity of quinolones against mycobacteria.
    Jacobs MR.
    Drugs; 1999 Apr; 58 Suppl 2():19-22. PubMed ID: 10553700
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
    Wolff KA, Nguyen HT, Cartabuke RH, Singh A, Ogwang S, Nguyen L.
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3515-9. PubMed ID: 19528288
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M, Gutierrez J, Ruiz P, Moreno G.
    Chemotherapy; 1995 Aug; 41(3):204-7. PubMed ID: 7656667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
    Schedletzky H, Wiedemann B, Heisig P.
    J Antimicrob Chemother; 1999 May; 43 Suppl B():31-7. PubMed ID: 10382873
    [Abstract] [Full Text] [Related]

  • 14. Fluoroquinolone resistance: mechanisms and epidemiology.
    Tillotson GS, Dorrian I, Blondeau J.
    J Med Microbiol; 1997 Jun; 46(6):457-61. PubMed ID: 9379475
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activity of moxifloxacin against mycobacteria.
    Gillespie SH, Billington O.
    J Antimicrob Chemother; 1999 Sep; 44(3):393-5. PubMed ID: 10511409
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serotyping of quinolone-resistant Neisseria gonorrhoeae isolates with alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Maeda SI, Saito I, Kawada Y.
    J Antimicrob Chemother; 1998 Mar; 41(3):418-20. PubMed ID: 9578173
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.